Media Contacts

Corporate

Monica Neufang
Phone: 215 325-4250
mneufan@its.jnj.com

Dermatology

Craig Stoltz
Phone: 215 325-3612
cstoltz@its.jnj.com

Gastroenterology

Linda Davis
Phone: 215 325-3562
ldavis9@its.jnj.com

Rheumatology

Megan Farina
Phone: 215-325-6861
mfarina@its.jnj.com

Oncology/Nephrology

Lisa Vaga
908-218-7316
lvaga@its.jnj.com

Press Releases

12/08/2011

Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765

12/02/2011

CASEY ABRAMS ANNOUNCES WINNERS OF INFLAMMATORY BOWEL DISEASE AWARENESS CAMPAIGN AFTER A NATIONAL VOTE

09/29/2011

CASEY ABRAMS ANNOUNCES FINALISTS IN NATIONAL INFLAMMATORY BOWEL DISEASE AWARENESS CAMPAIGN AND CALLS ON AMERICA TO VOTE

09/26/2011

REMICADE^® RECEIVES FDA APPROVAL AS FIRST BIOLOGIC TREATMENT FOR PEDIATRIC ULCERATIVE COLITIS

09/09/2011

FDA ISSUES COMPLETE RESPONSE LETTER TO JANSSEN BIOTECH, INC. FOR SIMPONI^® SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION

07/25/2011

AMERICAN IDOL CONTESTANT CASEY ABRAMS LAUNCHES NATIONWIDE CONTEST TO RAISE AWARENESS ABOUT INFLAMMATORY BOWEL DISEASE

07/22/2011

FDA ISSUES COMPLETE RESPONSE LETTER TO JANSSEN BIOTECH, INC. FOR SIMPONI^® SUPPLEMENTAL BIOLOGIC LICENSE APPLICATION

07/21/2011

FDA ADVISORY COMMITTEE RECOMMENDS APPROVAL OF REMICADE^® FOR TREATMENT OF PEDIATRIC ULCERATIVE COLITIS

06/24/2011

Janssen Products LP modifies prescribing information for PROCRIT^® (Epoetin alfa) in Chronic Kidney Disease

06/22/2011

Biotechnology industry leader Centocor Ortho Biotech is now Janssen Biotech, Inc., part of the Janssen Pharmaceutical Companies

Janssen Biotech, Inc.

© Janssen Biotech, Inc. 2011. All Rights Reserved. Your use of the information on this site is subject to the terms of our Legal Notice. Please see our Privacy Policy,
Safe Harbor Privacy Policy. This site is published by Janssen Biotech, Inc., which is solely responsible for its contents. Capitalized product names are trademarks of Janssen Biotech, Inc. This information is intended for use by our customers, patients and healthcare professionals in the United States only. Janssen Biotech, Inc. recognizes that the internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The prescribing information included here may not be appropriate for use outside the United States.

This page was last modified on: Jan 20 2012 at 13:33:12 EDT